Safety & Risk: Synthetic, Converted, Natural Cannabinoids
Safety & Risk: Synthetic, Converted, Natural Cannabinoids
Not all cannabinoids are created equal. This session clarifies the differences between naturally occurring, converted, and synthetic cannabinoids — addressing the science, safety data, and regulatory considerations needed to ensure consumer protection in a rapidly innovating market. This session will also discuss if/when/how these distinctions matter to the government and consumers.
Nicholas MORTILLARO
Safety & Risk: Synthetic, Converted, Natural Cannabinoids
Experienced process design and product development engineer with a history of success in the biotechnology and cannabis industries. Expertise in biosynthesis, extraction and formulation of cannabinoid therapeutics. Consultant in strategic marketing, engineering project management, process engineering, tech transfer and commercial scale-up operations.
Owner/Investor/Partner in LazyDaze Coffeeshops, Botanic Bliss, ViceVending and Aim High Hemp Distro.